Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · Real-Time Price · USD
36.77
+0.25 (0.68%)
At close: Aug 14, 2026, 4:00 PM EDT
36.75
-0.02 (-0.05%)
After-hours: Aug 14, 2026, 7:50 PM EDT

Teva Pharmaceutical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
42,84835,80725,00611,70310,1298,835
Market Cap Growth
117.03%43.19%113.68%15.54%14.65%-16.46%
Enterprise Value
56,08750,69941,28130,33430,27531,945
Last Close Price
36.7731.2122.0410.449.128.01
PE Ratio
61.1125.40---21.19
Forward PE
13.0612.078.354.213.633.02
PS Ratio
2.472.081.510.740.680.56
PB Ratio
5.534.524.371.441.180.79
P/FCF Ratio
31.8131.1933.3913.909.7237.44
P/OCF Ratio
22.5821.7120.058.566.3711.07
PEG Ratio
2.181.826.690.401.630.68
EV/Sales Ratio
3.242.942.501.912.032.01
EV/EBITDA Ratio
13.1410.239.316.997.637.25
EV/EBIT Ratio
17.1012.8312.249.5211.3710.38
EV/FCF Ratio
41.6444.1655.1236.0329.06135.36
Debt / Equity Ratio
2.182.183.182.502.522.10
Debt / EBITDA Ratio
3.843.393.984.535.265.19
Debt / FCF Ratio
12.5415.0124.2824.0820.8099.97
Net Debt / Equity Ratio
1.711.732.602.102.191.91
Net Debt / EBITDA Ratio
3.102.763.363.934.754.86
Net Debt / FCF Ratio
9.8311.9119.8720.2518.1190.80
Asset Turnover
0.430.430.400.360.330.32
Inventory Turnover
2.452.692.412.092.082.02
Quick Ratio
0.460.540.500.540.570.61
Current Ratio
0.881.040.981.021.051.14
Return on Equity (ROE)
9.69%20.79%-28.30%-7.36%-25.19%4.09%
Return on Assets (ROA)
5.13%6.17%5.09%4.55%3.63%3.91%
Return on Invested Capital (ROIC)
15.21%18.73%14.74%12.10%8.85%6.18%
Return on Capital Employed (ROCE)
13.50%14.50%12.70%10.20%8.20%8.40%
Earnings Yield
1.65%3.94%-6.55%-4.78%-24.15%4.72%
FCF Yield
3.14%3.21%3.00%7.20%10.29%2.67%
Buyback Yield / Dilution
-2.24%-2.83%-1.07%-0.81%-0.27%-1.10%
Total Shareholder Return
-2.24%-2.83%-1.07%-0.81%-0.27%-1.10%
SEC Filings: 10-K · 10-Q